ArticlePloS one2026
Cognitive impairment and depressive symptoms to predict renal outcome and mortality in older adult patients.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive impairment and depressive symptoms are common in older adults, but their impacts on adverse renal and survival outcomes remain unclear. This retrospective cohort study examined associations of cognitive impairment and depressive symptoms with renal replacement therapy (RRT) initiation and mortality among 5,191 adults aged ≥ 65 years. Cognitive impairment and depressive symptoms were assessed using the Korean Mini-Mental State Examination (MMSE-KC) and the Korean Short Geriatric Depression Scale (SGDS-K), respectively. During a mean follow-up of 45 months, 1,512 participants (29.1%) died and 68 (1.3%) initiated RRT. Depressive symptoms (SGDS-K score ≥ 5) were associated with increased risks of both incident RRT (HR 2.066, p = 0.004) and mortality (HR 1.565, p < 0.001). Cognitive impairment (MMSE-KC score ≤ 23) was associated with both incident RRT (HR 2.028, p = 0.007) and mortality (HR 1.728, p < 0.001). Subgroup analyses demonstrated that depressive symptoms remained associated with RRT risk across age groups and renal function strata, while cognitive impairment was linked to RRT primarily among those with preserved renal function or age < 75 years. Both factors were consistently associated with higher mortality across subgroups. Although receiver operating characteristic curve analysis showed comparable predictive value for RRT, cognitive impairment demonstrated greater discriminative ability for mortality. These findings suggest that depressive symptoms may serve as a relevant marker of renal deterioration requiring RRT, whereas cognitive impairment may more closely reflect mortality risk. Routine psychological and cognitive assessments may support early identification of high-risk patients and inform prevention strategies in geriatric care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.